nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—psoriasis—atopic dermatitis	0.743	1	CtDrD
Tazarotene—CYP2C8—Mometasone—atopic dermatitis	0.0529	0.478	CbGbCtD
Tazarotene—CYP2C8—Loratadine—atopic dermatitis	0.0304	0.274	CbGbCtD
Tazarotene—CYP2C8—Hydrocortisone—atopic dermatitis	0.0169	0.153	CbGbCtD
Tazarotene—CYP2C8—Dexamethasone—atopic dermatitis	0.0105	0.095	CbGbCtD
Tazarotene—Impetigo—Pimecrolimus—atopic dermatitis	0.00727	0.0509	CcSEcCtD
Tazarotene—Application site rash—Desonide—atopic dermatitis	0.00543	0.038	CcSEcCtD
Tazarotene—Application site erythema—Desonide—atopic dermatitis	0.00503	0.0352	CcSEcCtD
Tazarotene—Application site pruritus—Desonide—atopic dermatitis	0.00486	0.034	CcSEcCtD
Tazarotene—Phototoxicity—Pimecrolimus—atopic dermatitis	0.00437	0.0306	CcSEcCtD
Tazarotene—Application site irritation—Desonide—atopic dermatitis	0.00427	0.0299	CcSEcCtD
Tazarotene—Impetigo—Tacrolimus—atopic dermatitis	0.00396	0.0277	CcSEcCtD
Tazarotene—Application site erythema—Pimecrolimus—atopic dermatitis	0.00356	0.0249	CcSEcCtD
Tazarotene—Application site pruritus—Pimecrolimus—atopic dermatitis	0.00343	0.024	CcSEcCtD
Tazarotene—Application site irritation—Pimecrolimus—atopic dermatitis	0.00302	0.0211	CcSEcCtD
Tazarotene—Leukoderma—Desonide—atopic dermatitis	0.00279	0.0195	CcSEcCtD
Tazarotene—Application site pain—Desonide—atopic dermatitis	0.0027	0.0189	CcSEcCtD
Tazarotene—Phototoxicity—Tacrolimus—atopic dermatitis	0.00238	0.0166	CcSEcCtD
Tazarotene—Sensitisation—Pimecrolimus—atopic dermatitis	0.00235	0.0164	CcSEcCtD
Tazarotene—Leukoderma—Fluocinonide—atopic dermatitis	0.00226	0.0158	CcSEcCtD
Tazarotene—Application site pain—Fluocinonide—atopic dermatitis	0.00219	0.0153	CcSEcCtD
Tazarotene—Application site rash—Tacrolimus—atopic dermatitis	0.00209	0.0146	CcSEcCtD
Tazarotene—Leukoderma—Pimecrolimus—atopic dermatitis	0.00197	0.0138	CcSEcCtD
Tazarotene—Application site erythema—Tacrolimus—atopic dermatitis	0.00193	0.0135	CcSEcCtD
Tazarotene—Application site pain—Pimecrolimus—atopic dermatitis	0.00191	0.0133	CcSEcCtD
Tazarotene—Application site pruritus—Tacrolimus—atopic dermatitis	0.00187	0.0131	CcSEcCtD
Tazarotene—Application site irritation—Tacrolimus—atopic dermatitis	0.00164	0.0115	CcSEcCtD
Tazarotene—Sensitisation—Mometasone—atopic dermatitis	0.0016	0.0112	CcSEcCtD
Tazarotene—Stinging—Desonide—atopic dermatitis	0.00146	0.0102	CcSEcCtD
Tazarotene—Leukoderma—Fluocinolone Acetonide—atopic dermatitis	0.00141	0.00987	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Pimecrolimus—atopic dermatitis	0.00141	0.00985	CcSEcCtD
Tazarotene—Instillation site pain—Tacrolimus—atopic dermatitis	0.0014	0.00978	CcSEcCtD
Tazarotene—Skin irritation—Fluocinolone Acetonide—atopic dermatitis	0.00139	0.0097	CcSEcCtD
Tazarotene—Leukoderma—Mometasone—atopic dermatitis	0.00135	0.00942	CcSEcCtD
Tazarotene—Dermatitis contact—Desonide—atopic dermatitis	0.00117	0.0082	CcSEcCtD
Tazarotene—Skin exfoliation—Desonide—atopic dermatitis	0.00113	0.00792	CcSEcCtD
Tazarotene—Leukoderma—Tacrolimus—atopic dermatitis	0.00107	0.0075	CcSEcCtD
Tazarotene—Skin irritation—Tacrolimus—atopic dermatitis	0.00105	0.00737	CcSEcCtD
Tazarotene—Application site pain—Tacrolimus—atopic dermatitis	0.00104	0.00725	CcSEcCtD
Tazarotene—Application site irritation—Hydrocortisone—atopic dermatitis	0.00102	0.00717	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Fluocinolone Acetonide—atopic dermatitis	0.00101	0.00705	CcSEcCtD
Tazarotene—Acne—Pimecrolimus—atopic dermatitis	0.000996	0.00697	CcSEcCtD
Tazarotene—Localized exfoliation—Triamcinolone—atopic dermatitis	0.000994	0.00695	CcSEcCtD
Tazarotene—Dermatitis contact—Fluocinonide—atopic dermatitis	0.00095	0.00664	CcSEcCtD
Tazarotene—Skin discolouration—Pimecrolimus—atopic dermatitis	0.000928	0.00649	CcSEcCtD
Tazarotene—Blister—Loratadine—atopic dermatitis	0.000926	0.00648	CcSEcCtD
Tazarotene—Skin exfoliation—Fluocinonide—atopic dermatitis	0.000918	0.00642	CcSEcCtD
Tazarotene—Skin exfoliation—Pimecrolimus—atopic dermatitis	0.0008	0.0056	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Tacrolimus—atopic dermatitis	0.000794	0.00555	CcSEcCtD
Tazarotene—Swelling—Fluocinonide—atopic dermatitis	0.000791	0.00553	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Tacrolimus—atopic dermatitis	0.000766	0.00536	CcSEcCtD
Tazarotene—Stinging—Mometasone—atopic dermatitis	0.000707	0.00495	CcSEcCtD
Tazarotene—Blood triglycerides increased—Tacrolimus—atopic dermatitis	0.000696	0.00487	CcSEcCtD
Tazarotene—Swelling—Pimecrolimus—atopic dermatitis	0.000689	0.00482	CcSEcCtD
Tazarotene—Leukoderma—Prednisolone—atopic dermatitis	0.000685	0.00479	CcSEcCtD
Tazarotene—Leukoderma—Hydrocortisone—atopic dermatitis	0.000669	0.00468	CcSEcCtD
Tazarotene—Skin irritation—Hydrocortisone—atopic dermatitis	0.000658	0.0046	CcSEcCtD
Tazarotene—Burning sensation—Tacrolimus—atopic dermatitis	0.000656	0.00459	CcSEcCtD
Tazarotene—Application site pain—Hydrocortisone—atopic dermatitis	0.000647	0.00452	CcSEcCtD
Tazarotene—Dry skin—Fluocinonide—atopic dermatitis	0.00064	0.00447	CcSEcCtD
Tazarotene—Skin discolouration—Mometasone—atopic dermatitis	0.000634	0.00444	CcSEcCtD
Tazarotene—Leukoderma—Triamcinolone—atopic dermatitis	0.00063	0.00441	CcSEcCtD
Tazarotene—Leukoderma—Methylprednisolone—atopic dermatitis	0.000628	0.0044	CcSEcCtD
Tazarotene—Dermatitis contact—Fluocinolone Acetonide—atopic dermatitis	0.000593	0.00415	CcSEcCtD
Tazarotene—Oedema peripheral—Desonide—atopic dermatitis	0.000587	0.00411	CcSEcCtD
Tazarotene—Leukoderma—Dexamethasone—atopic dermatitis	0.000572	0.004	CcSEcCtD
Tazarotene—Leukoderma—Betamethasone—atopic dermatitis	0.000572	0.004	CcSEcCtD
Tazarotene—Dermatitis contact—Mometasone—atopic dermatitis	0.000566	0.00396	CcSEcCtD
Tazarotene—Acne—Tacrolimus—atopic dermatitis	0.000542	0.00379	CcSEcCtD
Tazarotene—Erythema—Desonide—atopic dermatitis	0.000519	0.00363	CcSEcCtD
Tazarotene—Dermatitis bullous—Loratadine—atopic dermatitis	0.000507	0.00355	CcSEcCtD
Tazarotene—Skin discolouration—Tacrolimus—atopic dermatitis	0.000505	0.00353	CcSEcCtD
Tazarotene—Leukoderma—Prednisone—atopic dermatitis	0.000498	0.00348	CcSEcCtD
Tazarotene—Photosensitivity reaction—Dimenhydrinate—atopic dermatitis	0.000496	0.00347	CcSEcCtD
Tazarotene—Photosensitivity reaction—Diphenhydramine—atopic dermatitis	0.000496	0.00347	CcSEcCtD
Tazarotene—Eczema—Fluocinolone Acetonide—atopic dermatitis	0.000485	0.00339	CcSEcCtD
Tazarotene—Photosensitivity reaction—Pimecrolimus—atopic dermatitis	0.00048	0.00336	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Hydrocortisone—atopic dermatitis	0.000478	0.00334	CcSEcCtD
Tazarotene—Inflammation—Tacrolimus—atopic dermatitis	0.00047	0.00329	CcSEcCtD
Tazarotene—Dermatitis contact—Tacrolimus—atopic dermatitis	0.000451	0.00315	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Triamcinolone—atopic dermatitis	0.00045	0.00315	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Methylprednisolone—atopic dermatitis	0.000449	0.00314	CcSEcCtD
Tazarotene—Erythema—Fluocinonide—atopic dermatitis	0.00042	0.00294	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Dexamethasone—atopic dermatitis	0.000408	0.00286	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Betamethasone—atopic dermatitis	0.000408	0.00286	CcSEcCtD
Tazarotene—Blister—Prednisolone—atopic dermatitis	0.000404	0.00283	CcSEcCtD
Tazarotene—Blister—Triamcinolone—atopic dermatitis	0.000371	0.0026	CcSEcCtD
Tazarotene—Hypertriglyceridaemia—Prednisone—atopic dermatitis	0.000368	0.00258	CcSEcCtD
Tazarotene—Eczema—Tacrolimus—atopic dermatitis	0.000368	0.00258	CcSEcCtD
Tazarotene—Erythema—Pimecrolimus—atopic dermatitis	0.000366	0.00256	CcSEcCtD
Tazarotene—Pain—Desonide—atopic dermatitis	0.000362	0.00253	CcSEcCtD
Tazarotene—Stinging—Prednisolone—atopic dermatitis	0.000359	0.00251	CcSEcCtD
Tazarotene—Stinging—Hydrocortisone—atopic dermatitis	0.000351	0.00246	CcSEcCtD
Tazarotene—Dermatitis bullous—Tacrolimus—atopic dermatitis	0.000346	0.00242	CcSEcCtD
Tazarotene—Acne—Prednisolone—atopic dermatitis	0.000346	0.00242	CcSEcCtD
Tazarotene—Acne—Hydrocortisone—atopic dermatitis	0.000338	0.00236	CcSEcCtD
Tazarotene—Blister—Dexamethasone—atopic dermatitis	0.000337	0.00236	CcSEcCtD
Tazarotene—Blister—Betamethasone—atopic dermatitis	0.000337	0.00236	CcSEcCtD
Tazarotene—Stinging—Triamcinolone—atopic dermatitis	0.000331	0.00231	CcSEcCtD
Tazarotene—Blood triglycerides increased—Prednisone—atopic dermatitis	0.000323	0.00226	CcSEcCtD
Tazarotene—Acne—Triamcinolone—atopic dermatitis	0.000318	0.00223	CcSEcCtD
Tazarotene—Acne—Methylprednisolone—atopic dermatitis	0.000318	0.00222	CcSEcCtD
Tazarotene—Skin discolouration—Hydrocortisone—atopic dermatitis	0.000315	0.0022	CcSEcCtD
Tazarotene—Dry skin—Tacrolimus—atopic dermatitis	0.000303	0.00212	CcSEcCtD
Tazarotene—Stinging—Dexamethasone—atopic dermatitis	0.0003	0.0021	CcSEcCtD
Tazarotene—Stinging—Betamethasone—atopic dermatitis	0.0003	0.0021	CcSEcCtD
Tazarotene—Pruritus—Desonide—atopic dermatitis	0.000299	0.00209	CcSEcCtD
Tazarotene—Oedema—Pimecrolimus—atopic dermatitis	0.000299	0.00209	CcSEcCtD
Tazarotene—Pain—Fluocinonide—atopic dermatitis	0.000293	0.00205	CcSEcCtD
Tazarotene—Inflammation—Hydrocortisone—atopic dermatitis	0.000293	0.00205	CcSEcCtD
Tazarotene—Acne—Dexamethasone—atopic dermatitis	0.000289	0.00202	CcSEcCtD
Tazarotene—Acne—Betamethasone—atopic dermatitis	0.000289	0.00202	CcSEcCtD
Tazarotene—Dermatitis contact—Hydrocortisone—atopic dermatitis	0.000281	0.00197	CcSEcCtD
Tazarotene—Inflammation—Methylprednisolone—atopic dermatitis	0.000275	0.00193	CcSEcCtD
Tazarotene—Skin exfoliation—Hydrocortisone—atopic dermatitis	0.000271	0.0019	CcSEcCtD
Tazarotene—Rash—Desonide—atopic dermatitis	0.000267	0.00187	CcSEcCtD
Tazarotene—Dermatitis—Desonide—atopic dermatitis	0.000267	0.00186	CcSEcCtD
Tazarotene—Dermatitis contact—Triamcinolone—atopic dermatitis	0.000265	0.00185	CcSEcCtD
Tazarotene—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.000262	0.00183	CcSEcCtD
Tazarotene—Photosensitivity reaction—Tacrolimus—atopic dermatitis	0.000261	0.00183	CcSEcCtD
Tazarotene—Pain—Pimecrolimus—atopic dermatitis	0.000256	0.00179	CcSEcCtD
Tazarotene—Skin exfoliation—Triamcinolone—atopic dermatitis	0.000256	0.00179	CcSEcCtD
Tazarotene—Skin exfoliation—Methylprednisolone—atopic dermatitis	0.000255	0.00178	CcSEcCtD
Tazarotene—Acne—Prednisone—atopic dermatitis	0.000251	0.00176	CcSEcCtD
Tazarotene—Discomfort—Loratadine—atopic dermatitis	0.000245	0.00172	CcSEcCtD
Tazarotene—Pruritus—Fluocinonide—atopic dermatitis	0.000243	0.0017	CcSEcCtD
Tazarotene—Dermatitis contact—Dexamethasone—atopic dermatitis	0.00024	0.00168	CcSEcCtD
Tazarotene—Dermatitis contact—Betamethasone—atopic dermatitis	0.00024	0.00168	CcSEcCtD
Tazarotene—Skin exfoliation—Dexamethasone—atopic dermatitis	0.000232	0.00162	CcSEcCtD
Tazarotene—Skin exfoliation—Betamethasone—atopic dermatitis	0.000232	0.00162	CcSEcCtD
Tazarotene—Haemoglobin—Tacrolimus—atopic dermatitis	0.00023	0.00161	CcSEcCtD
Tazarotene—Eczema—Hydrocortisone—atopic dermatitis	0.00023	0.00161	CcSEcCtD
Tazarotene—Haemorrhage—Tacrolimus—atopic dermatitis	0.000229	0.0016	CcSEcCtD
Tazarotene—Oedema peripheral—Tacrolimus—atopic dermatitis	0.000226	0.00158	CcSEcCtD
Tazarotene—Dermatitis bullous—Prednisolone—atopic dermatitis	0.000221	0.00155	CcSEcCtD
Tazarotene—Rash—Fluocinonide—atopic dermatitis	0.000216	0.00151	CcSEcCtD
Tazarotene—Dermatitis—Fluocinonide—atopic dermatitis	0.000216	0.00151	CcSEcCtD
Tazarotene—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.000214	0.0015	CcSEcCtD
Tazarotene—Pruritus—Pimecrolimus—atopic dermatitis	0.000212	0.00148	CcSEcCtD
Tazarotene—Pain—Loratadine—atopic dermatitis	0.000204	0.00142	CcSEcCtD
Tazarotene—Dermatitis bullous—Triamcinolone—atopic dermatitis	0.000203	0.00142	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000203	0.0579	CbGpPWpGaD
Tazarotene—Skin exfoliation—Prednisone—atopic dermatitis	0.000202	0.00141	CcSEcCtD
Tazarotene—Erythema—Tacrolimus—atopic dermatitis	0.000199	0.00139	CcSEcCtD
Tazarotene—Rash—Dimenhydrinate—atopic dermatitis	0.000195	0.00136	CcSEcCtD
Tazarotene—Rash—Diphenhydramine—atopic dermatitis	0.000195	0.00136	CcSEcCtD
Tazarotene—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000195	0.00136	CcSEcCtD
Tazarotene—Dermatitis—Diphenhydramine—atopic dermatitis	0.000195	0.00136	CcSEcCtD
Tazarotene—Dry skin—Prednisolone—atopic dermatitis	0.000194	0.00136	CcSEcCtD
Tazarotene—Dry skin—Hydrocortisone—atopic dermatitis	0.000189	0.00132	CcSEcCtD
Tazarotene—Rash—Pimecrolimus—atopic dermatitis	0.000188	0.00132	CcSEcCtD
Tazarotene—Dermatitis—Pimecrolimus—atopic dermatitis	0.000188	0.00132	CcSEcCtD
Tazarotene—Dermatitis bullous—Betamethasone—atopic dermatitis	0.000185	0.00129	CcSEcCtD
Tazarotene—Dermatitis bullous—Dexamethasone—atopic dermatitis	0.000185	0.00129	CcSEcCtD
Tazarotene—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000183	0.00128	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000182	0.052	CbGpPWpGaD
Tazarotene—Pain—Mometasone—atopic dermatitis	0.000175	0.00122	CcSEcCtD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000174	0.0498	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000174	0.0498	CbGpPWpGaD
Tazarotene—Discomfort—Tacrolimus—atopic dermatitis	0.000168	0.00117	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000164	0.0467	CbGpPWpGaD
Tazarotene—Oedema—Tacrolimus—atopic dermatitis	0.000163	0.00114	CcSEcCtD
Tazarotene—Dry skin—Dexamethasone—atopic dermatitis	0.000162	0.00113	CcSEcCtD
Tazarotene—Dry skin—Betamethasone—atopic dermatitis	0.000162	0.00113	CcSEcCtD
Tazarotene—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000151	0.00106	CcSEcCtD
Tazarotene—Rash—Loratadine—atopic dermatitis	0.00015	0.00105	CcSEcCtD
Tazarotene—Dermatitis—Loratadine—atopic dermatitis	0.00015	0.00105	CcSEcCtD
Tazarotene—RARG—Nuclear Receptors—PPARA—atopic dermatitis	0.00015	0.0428	CbGpPWpGaD
Tazarotene—Haemoglobin—Prednisolone—atopic dermatitis	0.000147	0.00103	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000147	0.0419	CbGpPWpGaD
Tazarotene—Haemorrhage—Prednisolone—atopic dermatitis	0.000146	0.00102	CcSEcCtD
Tazarotene—Pruritus—Mometasone—atopic dermatitis	0.000145	0.00101	CcSEcCtD
Tazarotene—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000144	0.001	CcSEcCtD
Tazarotene—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000143	0.000999	CcSEcCtD
Tazarotene—Dry skin—Prednisone—atopic dermatitis	0.000141	0.000985	CcSEcCtD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000141	0.0402	CbGpPWpGaD
Tazarotene—Pain—Tacrolimus—atopic dermatitis	0.000139	0.000973	CcSEcCtD
Tazarotene—Haemoglobin—Triamcinolone—atopic dermatitis	0.000135	0.000945	CcSEcCtD
Tazarotene—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000135	0.000944	CcSEcCtD
Tazarotene—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000135	0.000943	CcSEcCtD
Tazarotene—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000135	0.000943	CcSEcCtD
Tazarotene—Haemorrhage—Triamcinolone—atopic dermatitis	0.000134	0.000941	CcSEcCtD
Tazarotene—RARB—Nuclear Receptors—PPARA—atopic dermatitis	0.000134	0.0384	CbGpPWpGaD
Tazarotene—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000134	0.000939	CcSEcCtD
Tazarotene—Rash—Mometasone—atopic dermatitis	0.000129	0.000901	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptors—PPARA—atopic dermatitis	0.000129	0.0368	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARA—atopic dermatitis	0.000129	0.0368	CbGpPWpGaD
Tazarotene—Dermatitis—Mometasone—atopic dermatitis	0.000129	0.0009	CcSEcCtD
Tazarotene—Erythema—Prednisolone—atopic dermatitis	0.000127	0.00089	CcSEcCtD
Tazarotene—Erythema—Hydrocortisone—atopic dermatitis	0.000124	0.00087	CcSEcCtD
Tazarotene—Haemoglobin—Betamethasone—atopic dermatitis	0.000123	0.000858	CcSEcCtD
Tazarotene—Haemoglobin—Dexamethasone—atopic dermatitis	0.000123	0.000858	CcSEcCtD
Tazarotene—Haemorrhage—Betamethasone—atopic dermatitis	0.000122	0.000853	CcSEcCtD
Tazarotene—Haemorrhage—Dexamethasone—atopic dermatitis	0.000122	0.000853	CcSEcCtD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000118	0.0338	CbGpPWpGaD
Tazarotene—Erythema—Triamcinolone—atopic dermatitis	0.000117	0.000819	CcSEcCtD
Tazarotene—Erythema—Methylprednisolone—atopic dermatitis	0.000117	0.000817	CcSEcCtD
Tazarotene—Pruritus—Tacrolimus—atopic dermatitis	0.000115	0.000805	CcSEcCtD
Tazarotene—Discomfort—Prednisolone—atopic dermatitis	0.000107	0.000749	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—atopic dermatitis	0.000107	0.000747	CcSEcCtD
Tazarotene—Haemorrhage—Prednisone—atopic dermatitis	0.000106	0.000743	CcSEcCtD
Tazarotene—Erythema—Betamethasone—atopic dermatitis	0.000106	0.000743	CcSEcCtD
Tazarotene—Erythema—Dexamethasone—atopic dermatitis	0.000106	0.000743	CcSEcCtD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000106	0.0303	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT6—atopic dermatitis	0.000106	0.0302	CbGpPWpGaD
Tazarotene—Discomfort—Hydrocortisone—atopic dermatitis	0.000105	0.000731	CcSEcCtD
Tazarotene—Oedema—Prednisolone—atopic dermatitis	0.000104	0.000727	CcSEcCtD
Tazarotene—Rash—Tacrolimus—atopic dermatitis	0.000103	0.000717	CcSEcCtD
Tazarotene—Dermatitis—Tacrolimus—atopic dermatitis	0.000102	0.000717	CcSEcCtD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000102	0.0291	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000102	0.0291	CbGpPWpGaD
Tazarotene—Oedema—Hydrocortisone—atopic dermatitis	0.000101	0.00071	CcSEcCtD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.0001	0.0287	CbGpPWpGaD
Tazarotene—Discomfort—Triamcinolone—atopic dermatitis	9.85e-05	0.000689	CcSEcCtD
Tazarotene—Discomfort—Methylprednisolone—atopic dermatitis	9.82e-05	0.000687	CcSEcCtD
Tazarotene—Oedema—Triamcinolone—atopic dermatitis	9.55e-05	0.000668	CcSEcCtD
Tazarotene—Erythema—Prednisone—atopic dermatitis	9.25e-05	0.000647	CcSEcCtD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	9e-05	0.0257	CbGpPWpGaD
Tazarotene—Discomfort—Betamethasone—atopic dermatitis	8.93e-05	0.000625	CcSEcCtD
Tazarotene—Discomfort—Dexamethasone—atopic dermatitis	8.93e-05	0.000625	CcSEcCtD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	8.91e-05	0.0254	CbGpPWpGaD
Tazarotene—Pain—Prednisolone—atopic dermatitis	8.88e-05	0.000621	CcSEcCtD
Tazarotene—Pain—Hydrocortisone—atopic dermatitis	8.68e-05	0.000607	CcSEcCtD
Tazarotene—Oedema—Dexamethasone—atopic dermatitis	8.67e-05	0.000606	CcSEcCtD
Tazarotene—Oedema—Betamethasone—atopic dermatitis	8.67e-05	0.000606	CcSEcCtD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	8.63e-05	0.0246	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	8.63e-05	0.0246	CbGpPWpGaD
Tazarotene—Pain—Triamcinolone—atopic dermatitis	8.17e-05	0.000571	CcSEcCtD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	7.99e-05	0.0228	CbGpPWpGaD
Tazarotene—Discomfort—Prednisone—atopic dermatitis	7.78e-05	0.000544	CcSEcCtD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	7.66e-05	0.0219	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	7.66e-05	0.0219	CbGpPWpGaD
Tazarotene—Oedema—Prednisone—atopic dermatitis	7.55e-05	0.000528	CcSEcCtD
Tazarotene—Pain—Dexamethasone—atopic dermatitis	7.41e-05	0.000519	CcSEcCtD
Tazarotene—Pain—Betamethasone—atopic dermatitis	7.41e-05	0.000519	CcSEcCtD
Tazarotene—Pruritus—Hydrocortisone—atopic dermatitis	7.18e-05	0.000502	CcSEcCtD
Tazarotene—Pruritus—Triamcinolone—atopic dermatitis	6.76e-05	0.000473	CcSEcCtD
Tazarotene—Pruritus—Methylprednisolone—atopic dermatitis	6.74e-05	0.000472	CcSEcCtD
Tazarotene—Rash—Prednisolone—atopic dermatitis	6.55e-05	0.000458	CcSEcCtD
Tazarotene—Dermatitis—Prednisolone—atopic dermatitis	6.54e-05	0.000458	CcSEcCtD
Tazarotene—Rash—Hydrocortisone—atopic dermatitis	6.4e-05	0.000447	CcSEcCtD
Tazarotene—Dermatitis—Hydrocortisone—atopic dermatitis	6.39e-05	0.000447	CcSEcCtD
Tazarotene—Pruritus—Dexamethasone—atopic dermatitis	6.13e-05	0.000429	CcSEcCtD
Tazarotene—Pruritus—Betamethasone—atopic dermatitis	6.13e-05	0.000429	CcSEcCtD
Tazarotene—Rash—Triamcinolone—atopic dermatitis	6.02e-05	0.000421	CcSEcCtD
Tazarotene—Dermatitis—Triamcinolone—atopic dermatitis	6.02e-05	0.000421	CcSEcCtD
Tazarotene—Rash—Methylprednisolone—atopic dermatitis	6.01e-05	0.00042	CcSEcCtD
Tazarotene—Dermatitis—Methylprednisolone—atopic dermatitis	6e-05	0.00042	CcSEcCtD
Tazarotene—RXRB—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	5.47e-05	0.0156	CbGpPWpGaD
Tazarotene—Rash—Betamethasone—atopic dermatitis	5.47e-05	0.000382	CcSEcCtD
Tazarotene—Rash—Dexamethasone—atopic dermatitis	5.47e-05	0.000382	CcSEcCtD
Tazarotene—Dermatitis—Betamethasone—atopic dermatitis	5.46e-05	0.000382	CcSEcCtD
Tazarotene—Dermatitis—Dexamethasone—atopic dermatitis	5.46e-05	0.000382	CcSEcCtD
Tazarotene—Pruritus—Prednisone—atopic dermatitis	5.34e-05	0.000374	CcSEcCtD
Tazarotene—RARA—Adipogenesis—PPARA—atopic dermatitis	4.81e-05	0.0137	CbGpPWpGaD
Tazarotene—Rash—Prednisone—atopic dermatitis	4.76e-05	0.000333	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—atopic dermatitis	4.76e-05	0.000333	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.46e-05	0.0127	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.28e-05	0.0122	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.26e-05	0.00932	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.13e-05	0.00894	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.94e-05	0.00841	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.82e-05	0.00806	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—atopic dermatitis	2.11e-05	0.00603	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.05e-05	0.00585	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARA—atopic dermatitis	2.04e-05	0.00584	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.96e-05	0.00561	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARA—atopic dermatitis	1.83e-05	0.00524	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARA—atopic dermatitis	1.76e-05	0.00502	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARA—atopic dermatitis	1.76e-05	0.00502	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—atopic dermatitis	1.71e-05	0.00487	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.62e-05	0.00463	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.55e-05	0.00444	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.09e-05	0.00311	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARA—atopic dermatitis	9.84e-06	0.00281	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARA—atopic dermatitis	8.83e-06	0.00252	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARA—atopic dermatitis	8.46e-06	0.00242	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARA—atopic dermatitis	8.46e-06	0.00242	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GLB1—atopic dermatitis	4.85e-06	0.00138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ADSL—atopic dermatitis	4.65e-06	0.00133	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.53e-06	0.00101	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.57e-06	0.000449	CbGpPWpGaD
